Prevention & lipids

Cardiovascular Prevention among Healthcare Professionals: the European Society of Cardiology (ESC) Congress Cardiovascular Health Check 2025

Eur Heart JPublished Cross-sectional study

Authors' conclusion

HCPs showed important gaps in cardiovascular prevention, particularly regarding the use of guideline-recommended therapy

Study context

Population
Healthcare professionals attending the ESC Congress
Participants
1,366 vs 2,732
Exposure
Healthcare professionals (HCPs) vs matched general population
  • HCPsn = 1,366
  • Matched controlsn = 2,732reference
Outcome
CV risk profile among HCPs
Methodological detailsage- and sex-matched comparison
  • Age- and sex-matched comparison

Main finding

As reported in the abstract

GroupExcess body weightHypertensionHyperlipidaemiaEstablished atherosclerotic cardiovascular disease (ASCVD)Subclinical atherosclerosis (without established ASCVD)
HCPs46.8%23.2%22.7%11.1%21.8%

HCPs

Excess body weight46.8%
Hypertension23.2%
Hyperlipidaemia22.7%
Established atherosclerotic cardiovascular disease (ASCVD)11.1%
Subclinical atherosclerosis (without established ASCVD)21.8%

Observational data: associations, not effects.

Further findings

Unrecognised risk factors and awareness vs matched controls · unrecognised hyperlipidaemia · matched controls

P = 0.293

Unrecognised risk factors and awareness vs matched controls · unrecognised hypertension · matched controls

P = 0.079

Unrecognised risk factors and awareness vs matched controls · unrecognised diabetes · matched controls

P = 0.864

Unrecognised risk factors and awareness vs matched controls · awareness of hyperlipidaemia · matched controls

P = 0.049

Primary prevention: therapy use and target achievement · antihypertensive therapy use

P < 0.001

Primary prevention: therapy use and target achievement · glucose-lowering therapy use

P = 0.001

Primary prevention: therapy use and target achievement · LDL-C target achieved

P < 0.001

Primary prevention: therapy use and target achievement · SBP target achieved

P = 0.003

Secondary prevention among HCPs
41.4% · Lipid-lowering therapy use · Antiplatelet therapy use 9.2% · LDL-C target achieved (on lipid-lowering therapy) 22.2%

Original publication

Cardiovascular Prevention among Healthcare Professionals: the ESC Congress Cardiovascular Health Check 2025. Eur Heart J. Published 30 August 2026. doi:10.1093/eurheartj/ehag736

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.